Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Post-translational modifications in T cells in systemic erythematosus lupus

25 Jan 2021

Abstract excerpt

Systemic erythematosus lupus (SLE) is a classic autoimmune disease characterized by multiple autoantibodies and immune-mediated tissue damage. The aetiology of this disease is still unclear. A new drug, belimumab, which acts against the B-lymphocyte stimulator (BLyS), can effectively improve the condition of SLE patients, but it cannot resolve all SLE symptoms. The discovery of novel, precise therapeutic targets...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glycosylation and Glycoproteins Research
Share to Monoclonal and Polyclonal Antibodies Research
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33512488
DOI: 10.1093/rheumatology/keab095

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 21 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Post-translational modifications in T cells in systemic erythematosus lupusPMID 33512488Read ↗

Oxidative Stress Contributes to Inflammatory and Cellular Damage in Systemic Lupus Erythematosus: Cellular Markers and Molecular MechanismSemantic proximity Read ↗

Effects of Major Epigenetic Factors on Systemic Lupus ErythematosusSemantic proximity Read ↗

An updated review on abnormal epigenetic modifications in the pathogenesis of systemic lupus erythematosus.Semantic proximity Read ↗

The Real Culprit in Systemic Lupus Erythematosus: Abnormal Epigenetic RegulationSemantic proximity Read ↗

Recent advances in understanding pathogenesis and therapeutic strategies of Systemic Lupus Erythematosus.Semantic proximity Read ↗

Proteome analysis of lysine 2-hydroxyisobutyrylation in the peripheral blood of systemic lupus erythematosus patientsSemantic proximity Read ↗

DNA methylation changes on immune cells in Systemic Lupus ErythematosusSemantic proximity Read ↗

Post-Translational Modifications in Atopic Dermatitis: Current Research and Clinical RelevanceSemantic proximity Read ↗

The roles of ERAP1 and ERAP2 in autoimmunity and cancer immunity: New insights and perspective.Semantic proximity Read ↗

Protein Post‐Translational Modification‐Mediated Control of Type I Interferon Cascade SignalingSemantic proximity Read ↗

Post-translational modifications of cancer immune checkpoints: mechanisms and therapeutic strategiesSemantic proximity Read ↗

Unconventional protein post-translational modifications: the helmsmen in breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.